Drug Information

Drug General Information
Drug ID
D05SLM
Former ID
DIB010099
Drug Name
LY-2590443
Indication Migraine [ICD9: 346; ICD10:G43] Phase 2 [522513]
Company
Eli Lilly & Co
Target and Pathway
Target(s) Substance-P receptor Target Info Antagonist [543792]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Measles
PANTHER Pathway CCKR signaling map ST
Reactome G alpha (q) signalling events
WikiPathways SIDS Susceptibility Pathways
Gastrin-CREB signalling pathway via PKC and MAPK
Spinal Cord Injury
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 522513ClinicalTrials.gov (NCT00804973) Study in Subjects With Acute Migraines Headaches.. U.S. National Institutes of Health.
Ref 543792(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 360).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.